AUSTIN, Texas--(BUSINESS WIRE)--Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostics company focused on spine imaging informatics, announced today the close of more than $2 million in its Series B financing.
These new funds will support the continued commercialization of its VMA (Vertebral Motion Analysis) technology. OKI is currently in the process of a limited scale beta launch with strategic partners. These funds will also assist OKI in completing and expanding its enterprise platform to allow for assessments of the neck (cervical spine) in addition to its current lower back (lumbar) assessments ability.
The VMA is a proprietary technology platform that is designed to be used in conjunction with standard fluoroscopes, which are commonly available in hospitals and clinics. The fluoroscopes capture video x-ray-type images of the spine, while patients are assisted through a series of flexion, extension, and lateral bending movements. Proprietary image recognition software then tracks these video images to produce information about the movement at each vertebral level. The VMA has patented intellectual property and received clearance from the U.S. FDA earlier this year.
Paul Gunnoe, CEO of Ortho Kinematics, Inc., said, "We are excited about the strong interest being shown in the VMA by the investors, surgeons, payers, and other players in the spine category. With this Series B funding, OKI is well-positioned to advance its mission of revolutionizing the diagnostic side of the spine industry and becoming the new gold standard for spine motion assessments.”
About Ortho Kinematics
Ortho Kinematics is a privately held diagnostic technology company, focused on spine imaging informatics and committed to the idea that spine motion matters. The company is working with a group of leading clinicians, researchers and developers who are passionate about leveraging spine biomechanical data to improve the diagnosis and treatment of back pain.